An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte Activation
Jill A. Hollenbach(University of California, San Francisco), Stéphanie Gras(La Trobe University), Mark J. Pletcher(Cancer Research And Biostatistics), Corey Smith(QIMR Berghofer Medical Research Institute), Dhilshan Jayasinghe(La Trobe University), Michael J. Dewar-Oldis(La Trobe University), Sean Lin(University of California, San Francisco), Emily Ariens(AGRF Ltd), Ticiana D.J. Farias(University of Colorado Denver), Paul J. Norman(University of Colorado Denver), Noah D. Peyser(University of California, San Francisco), Katherine M. Kichula(University of North Carolina at Charlotte), Irvin Jose(La Trobe University), Emma J. Grant(La Trobe University), Martin Maiers(National Marrow Donor Program), Tasneem Yusufali(University of California, San Francisco), Peter J. Barnard(La Trobe University), Elissavet Kontou(Evangelismos Hospital), Lloyd D’Orsogna(The University of Western Australia), Gregory M. Marcus(University of California, San Francisco), Demetra S.M. Chatzileontiadou(La Trobe University), Kleio Ampelakiotou(Evangelismos Hospital), Jeffrey E. Olgin(University of California, San Francisco), Andrea Nguyen(Monash Health), Janesha C. Maddumage(La Trobe University), Anurag Adhikari(La Trobe University), Katerina Tarassi(Evangelismos Hospital), Tim R. Mercer(The University of Queensland), Rayo Suseno(University of California, San Francisco), Anshika Srivastava(University of California, San Francisco), Alexandra Tsirogianni(Evangelismos Hospital), Juliano André Boquett(University of California, San Francisco), Jamie Tuibeo(La Trobe University), Dimitrios Zoulas(La Trobe University)
Cited by 2
Related Papers
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria
|European Heart Journal|2010|1.6k
Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease
|New England Journal of Medicine|2010|1.3k
Arrhythmogenic right ventricular cardiomyopathy
|The Lancet|2009|929